Created in 2013 as a spinoff from Cephalon Inc. (TEVA group), CleveXel Pharma is a pharmaceutical company specializing in innovative treatments for diseases of the central nervous system.

The Company is developing a portfolio of drug candidates.Thanks to our unique expertise in diseases of the central nervous system and our know-how in drug development, we have strong assets to bring these molecules with high potential to clinical proof of concept, a critical stage for creation of value. Our partnership policy and our ability to identify molecules of therapeutic potential at an early stage are another strength of our model.